abs384.txt	objectives		this	study	examined	the	pattern	of	use	and	factors	predictingprolonged	prescription	opioid	medications	among	cancer	patients	followingtreatment	with	curative	intent	materials	and	methods		patients	diagnosed	with	cancer	over	a	3-year	period	at	alarge	urban	safety-net	hospital	were	included		univariate	and	multivariateanalyses	was	used	to	identify	factors	associated	with	continued	opioid	use	results		of	the	199	patients	included	in	the	study		38%	continued	to	receive	anopioid	prescription	well	beyond	the	acute	diagnosis	and	treatment	phase		mean	agewas	60	3	years		with	a	female	preponderance	(63%)		surgical	resection	only(31	6%)	and	the	combination	of	surgery		chemotherapy		and	radiation	(19	7%)	werethe	commonest	treatment	modalities		pain-related	comorbidities	predating	cancerdiagnosis	were	reported	in	53	3%	of	the	patients		and	about	33%	were	also	onpain-modifying	medications	(odds	ratio	[or]		3	58		95%	confidence	interval	[ci]	1	92-6	77		fisher	exact	test	p<0	001)		average	number	of	prescriptions	receivedper	patient	was	4	8	(range		1	to	31)		over	an	average	of	9	5	months	(range		1	2to	28	1	mo)		mean	morphine	milligram	equivalents	prescribed	per	prescription	was319	mg	(range		48	to	2475	mg)		according	to	multivariate	model		patients	whoreceived	chemotherapy	(or		7	25		95%	ci		2	09-25	17		p=0	0018)		or	pain-modifyingmedications	(or		4	61		95%	ci		2	25-9	44		p<0	0001)	were	significantly	morelikely	to	continue	to	receive	prescriptions	for	opioids	discussion		treatment	with	chemotherapy		pain-modifying	medications		cancerstage		and	interval	between	diagnosis	and	treatment	are	the	best	predictors	forcontinuous	opioid	use		the	current	epidemic	of	opioid	misuse	and	abuse	makesexamination	current	practices	and	identifification	of	areas	of	improvementimperative	
